Peppers and pain - The promise of capsaicin

被引:62
作者
Fusco, BM
Giacovazzo, M
机构
[1] Department of Clinical Medicine, University La Sapienza, Rome
[2] Department of Clinical Medicine, University La Sapienza, Policlinico Umberto I, 00161 Rome, Viale del Policlinico
关键词
D O I
10.2165/00003495-199753060-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Capsaicin, the most pungent ingredient in red peppers, has been used for centuries to remedy pain. Recently, its role has come under reinvestigation due to evidence that the drug acts selectively on a subpopulation of primary sensory neurons with a nociceptive function. These neurons, besides generating pain sensations, participate through an antidromic activation in the process known as neurogenic inflammation. The first exposure to capsaicin intensely activates these neurons in both senses (orthodromic:pain sensation; antidromic: local reddening, oedema etc.). After the first exposure, the neurons become insensitive to all further stimulation (including capsaicin itself). This evidence led to the proposal of capsaicin as a prototype of an agent producing selective analgesia. This perspective is radically different from previous 'folk medicine' cures, where the drug was used as a counter-irritating agent (i.e. for muscular pain). The new concept requires that capsaicin be repeatedly applied on the painful area to obtain the desensitisation of the sensory neurons. Following this idea, capsaicin has been used successfully in controlling pain in postherpetic neuralgia, diabetic neuropathy and other conditions of neuropathic pain. Furthermore, evidence indicates that capsaicin could also control the pain of osteoarthritis. Finally, repeated applications of the drug to the nasal mucosa result in the prevention of cluster headache attacks. On the basis of this evidence, capsaicin appears to be a promising prototype for obtaining selective analgesia in localised pain syndromes.
引用
收藏
页码:909 / 914
页数:6
相关论文
共 37 条
[1]   ORAL CAPSAICIN PROVIDES TEMPORARY RELIEF FOR ORAL MUCOSITIS PAIN SECONDARY TO CHEMOTHERAPY RADIATION-THERAPY [J].
BERGER, A ;
HENDERSON, M ;
NADOOLMAN, W ;
DUFFY, V ;
DOOPER, D ;
SABERSKI, L ;
BARTOSHUK, L .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (03) :243-248
[2]   TREATMENT OF CHRONIC POSTHERPETIC NEURALGIA WITH TOPICAL CAPSAICIN - A PRELIMINARY-STUDY [J].
BERNSTEIN, JE ;
BICKERS, DR ;
DAHL, MV ;
ROSHAL, JY .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 17 (01) :93-96
[3]  
BUCK SH, 1986, PHARMACOL REV, V38, P179
[4]   DEPLETION OF PRIMARY AFFERENT SUBSTANCE-P BY CAPSAICIN AND DIHYDROCAPSAICIN WITHOUT ALTERED THERMAL SENSITIVITY IN RATS [J].
BUCK, SH ;
MILLER, MS ;
BURKS, TF .
BRAIN RESEARCH, 1982, 233 (01) :216-220
[5]   MYELINATED AFFERENT FIBRES RESPONDING SPECIFICALLY TO NOXIOUS STIMULATION OF SKIN [J].
BURGESS, PR ;
PERL, ER .
JOURNAL OF PHYSIOLOGY-LONDON, 1967, 190 (03) :541-&
[6]  
*CAPS STUD GROUP, 1991, ARCH INTERN MED, V151, P2225
[7]   VASCULAR AND SENSORY RESPONSES OF HUMAN-SKIN TO MILD INJURY AFTER TOPICAL TREATMENT WITH CAPSAICIN [J].
CARPENTER, SE ;
LYNN, B .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (03) :755-758
[8]   TREATMENT OF REFLEX SYMPATHETIC DYSTROPHY WITH TOPICAL CAPSAICIN - CASE-REPORT [J].
CHESHIRE, WP ;
SNYDER, CR .
PAIN, 1990, 42 (03) :307-311
[9]  
DEAL CL, 1991, CLIN THER, V13, P383
[10]  
FUSCO BM, 1992, ANESTH ANALG, V74, P375